retatrutide heart arrhythmia Is (generic name) associated with cardiac arrhythmias? Retatrutide side effects: what the
Description
ISBN 0-671-69098-1

10.1038/s41586-019-1237-9 54 LoC

Semaglutide (Ozempic and Wegovy) resulted in a 14.9% reduction in body weight in clinical trials, while tirzepatide (Mounjaro and Zepbound) led to a 20.9% body weight reduction

There are no licensed retatrutide products on sale anywhere in the world as of May 2026

The standard escalation in phase 2 trials started at either 2 mg or 4 mg weekly, with increases every four weeks for up to 12 weeks, reaching maximum doses of 8-12 mg